Kevin M. Vannella - Concepedia

Author

Kevin M. Vannella

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

K M Vannella, K.M. Vannella, Kevin M Vannella, Kevin M. Vannella, Kevin Vannella, Kevin M. Vannella, Meghana Chaudhary

Publications

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health University of Michigan National Institutes of Health Clinical Center Center for Cancer Research

About

Kevin M. Vannella is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.5K
2	Allergy	3	3	829
3	Health Sciences	1	1	140
4	Natural Sciences	1	1	44
5	Social Sciences	1	1	68

Kevin M. Vannella

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 infection and persistence in the human body and brain at autopsy Sydney Stein, Sabrina Ramelli, Alison Grazioli, Nature Human BodyViral PersistenceSars-cov-2 InfectionCovid-19 PandemicViral Pathogenesis	2022	851
SARS-CoV-2 infection of the oral cavity and saliva Ni Huang, Paola Pérez, Takafumi Kato, Nature Medicine	2021	797
T <sub>H</sub> 2 and T <sub>H</sub> 17 inflammatory pathways are reciprocally regulated in asthma David F. Choy, Kevin M. Hart, Lee A. Borthwick, Science Translational Medicine AsthmaInflammatory Lung DiseaseLung InflammationImmunologyImmune Regulation	2015	438
New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M<sub>2</sub> activation in a CCL2/CCR2 axis Lei Sun, Marisa C. Louie, Kevin M. Vannella, American Journal of Physiology-Lung Cellular and Molecular Physiology Il-10-induced Lung FibrosisInflammatory Lung DiseaseLung InflammationImmunologyPathology	2010	251
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells Daniel Chauss, Tilo Freiwald, Reuben McGregor, Nature Immunology InflammationChronic Inflammatory DiseasesCytokineAutoimmune DiseasePro-inflammatory Programs	2021	190
Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis Kevin M. Vannella, Thirumalai R. Ramalingam, Lee A. Borthwick, Science Translational Medicine	2016	178
The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice Kristy A. Bauman, Scott H. Wettlaufer, Katsuhide Okunishi, Journal of Clinical Investigation Pge2 SynthesisLung InflammationPge2 GenerationLipid PeroxidationImmunology	2010	141
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β Kevin M. Hart, Thomas Fabre, Joshua Sciurba, Science Translational Medicine Liver FibrosisImmune RegulationImmunologyPathologyRenal Inflammation	2017	140
Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis Lee A. Borthwick, L Barron, Kevin M. Hart, Mucosal Immunology Macrophage BiologyInflammationCytokineFibrosisIl-13-dependent Lung Inflammation	2015	133
SARS-CoV-2 infection and persistence throughout the human body and brain Daniel S. Chertow, Sydney Stein, Sabrina Ramelli, Human BodyLong CovidViral PersistenceRespiratory DiseasesImmunodeficiencies	2021	132

Page 1